The Complete Guide to Pharmaceutical Competitive Intelligence

Elevate CI From Reporting to Influence

Competitive Intelligence That Drives Real Decisions

Transform how your organization anticipates competitors, interprets market signals, and drives strategic decisions across the drug development lifecycle.

This comprehensive guide, derived from Sedulo Group’s expert analysis, equips leaders in pharmaceutical and biotech strategy, commercial operations, and market access with an actionable framework for elevating competitive intelligence from reactive tracking to proactive advantage.

With this guide you will learn how to:

Download the Report

What’s Inside the Guide?

This guide breaks down practical, high-impact elements of a mature competitive intelligence program, including:

Key Insights You’ll Gain from the Guide

CI should inform strategic choices, not just validate assumptions.
The value of CI lies in analysis and synthesis, not aggregation.
CI should not be a launch-only activity; it must operate continuously from Phase 2 onward.
Organizations that rely only on public data are often operating with incomplete visibility.
Scenario-based planning reduces surprise and accelerates decision-making under uncertainty.
The maturity of a CI function is measured by its influence on executive decisions.